Entry Instance

HTTP 200 OK
Allow: GET, PUT, PATCH, DELETE, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "id": 1123375,
    "url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1123375/?format=api",
    "text_counter": 419,
    "type": "speech",
    "speaker_name": "Isiolo South, KPP",
    "speaker_title": "Hon. Abdi Tepo",
    "speaker": {
        "id": 13350,
        "legal_name": "Abdi Koropu Tepo",
        "slug": "abdi-koropu-tepo-2"
    },
    "content": " Thank you, Hon. Temporary Deputy Speaker. Before the interruption, I was saying that pursuant to Section 16 of the Statutory Instruments Act, the Committee held a pre-publication scrutiny meeting with the Ministry of Health on 5th February 2020 in Mombasa where various issues emerged. Further to that, the Committee held a further meeting with the Kenya Association of Manufacturers (KAM) taking into consideration the fact that in production of breast milk substitutes, the association needed to be consulted. That meeting was held on 23rd March 2021 where KAM raised issues. Hon. Temporary Deputy Speaker, the Committee asked the Ministry of Health to take into consideration several matters raised by the KAM. Further, KAM proposed to the Ministry of Health certain amendments majority of which were taken into consideration. Following the same concerns raised after publication, the Committee further held a joint meeting between the Ministry of Health and the Kenya Association of Manufacturers on Monday, 8th November 2021, in the mini-chamber. In that particular meeting, there were representatives from the United Nations International Children’s Emergency Fund (UNICEF) and a professor from the pediatric department of University of Nairobi (UoN), so that matters raised by KAM could be sorted out. After the meeting between the Ministry, KAM and several representatives, specific issues in contention were deliberated upon and a consensus reached. Therefore, the Committee having scrutinized Legal Notice No. 184 of 2021, in light of its conformity to the Constitution observed that: 1. The regulations were published in the Gazette on 27th August 2021 by Legal Notice No. 184 of 2021 and submitted and presented on time. 2. There was sufficient public participation; and, 3. Regulatory impact assessments were satisfactorily done. The Committee having examined the Breast Milk Substitutes Regulations against the Constitution, the interpretation and General Provisions Act, 2021, the Statutory Instruments Act, 2013 and Breast Milk Substitutes Control Act, 2012, pursuant to which they are made, recommends that the House approves the Breast Milk Substitutes Regulation vide Legal Notice No. 184 of 2021 with the exceptions of regulations 1, 2 and 27 (1), which the Committee proposes to be amended pursuant to Section 28(v) of the Breast milk Regulation Act, 2012."
}